Carlos Guimarães is the CEO at Biocancer Clinical Research in Brazil. Biocancer is an oncology-focused drug development services company which assists pharmaceutical, biotechnology, medical device and drug development services companies in accessing Brazil's large patient populations. Since 2006, he is responsible for the general administration of the company, including its strategic realignment for venture capital investment.
Previously, Guimarães was the director of a successful Brazilian biotech company where he was responsible for national and international expansion. He has a broad international experience, a strong ability to lead teams, and exceptional performance in the commercial area. Over the last 10 years he has been running different business and since May 2006, was in charge of leading Biocancer to a distinguished position in clinical trials in the world.
Carlos Guimaraes graduated with a degree in Business Administration from Federal University of Minas Gerais (UFMG) Brazil, and received his MBA Executive International degree at Fundação Dom Cabral (Brazil & Sauder Business School (Canada).
BIOCANCER was established in 2004, when its founders, Dr. Alberto Wainstein, M.D., Ph.D. and Dr. Ana Paula Drummond, Pharm.D, Ph.D, returned from their post-docs in the US. They had spent 4 years working at the best research oriented universities in the US. They defended their post-doctoral the...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
Carlos Guimarães Discusses Academic and Professional Background and Early Interest In Business
Carlos Guimarães Discusses Decision To Leave Family Business and Become Corporate Executive
Carlos Guimarães States Importance of Following Strong Clinical Research Protocols To Compete In Global Pharma Industry
Carlos Guimarães States Brazilian Law Prohibits Clinical Trial Participants From Being Paid
Carlos Guimarães States Company Homepage In In English and Decision Was Made To Position Company As Global Competitor
Carlos Guimarães States Partnership Must Have Solid Foundations That Are Maintained Daily
Carlos Guimarães States Importance of Initial Business Plan - Even If It Will Not Be Completely Followed
